Questionnaire for Late Effects After Immunotherapy

As more patients live longer after immunotherapy, more patients also experience chronic and late side effects. Current questionnaires are mainly based on acute side effects and do not fully reflect patients’ long-term experiences. In this MEDtalk, Debbie Madsen, MD and PhD student, Department of Oncology, Odense University Hospital, Denmark, presents a modified Delphi study aiming to identify the most important symptoms to monitor over time and develop a consensus-based questionnaire for research and clinical follow-up.